NCT00288366View on ClinicalTrials.gov

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
SchizophreniaSchizoaffective DisorderBipolar Disorder
Interventions
DRUG

ziprasidone vs. aripiprazole

ziprasidone vs. aripiprazole dosed according to package insert

DRUG

aripiprazole vs. ziprasidone

aripiprazole vs. ziprasidone dosed according to package insert

Trial Locations (1)

37212

Psychiatric Hospital at Vanderbilt, Nashville

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

collaborator

Pfizer

INDUSTRY

lead

Northwestern University

OTHER